Effects of Insulin-Like Growth Factor-I on Expression of Suppressor of Cytokine Signaling-3 in C2C12 Myotube

국문 초록 (Abstract)

SOCS-3와 IGF-I은 근육의 분화 과정 및 근비대 기전에 있어 매우 중요한 조절자 역할을 하는 유전자 및 성장인자이며, 최근 골격근에서 IGF-I과 SOCS-3 유전자의 상호작용에 관한 연구의 필요성이 제기되고 있다. 본 연구에서는 C2C12 myotube에서 IGF-I이 SOCS-3 유전자 발현에 미치는 영향에 대해 알아보기 위해 4일간 분화시킨 C2C12 myotube에 IGF-I을 다양한 농도(0-200 ng/ml) 및 시간(3-72 시간)에 따라 처리하였다. 그 결과 IGF-I이 SOCS-3 유전자의 단백질 발현을 시간 의존적으로 유의하게 증가시켰으며, 3 시간에서 mRNA 발현을 증가시키고, 시간이 지남에 따라 긴 시간에서는 농도 의존적으로 발현이 감소하였음을 알 수 있었다. 또한 면역형광 염색을 통해 IGF-I이 myotube에서 SOCS-3의 단백질을 발현시켰음을 뚜렷하게 관찰 할 수 있었다. 위 결과들을 바탕으로 본 연구에서는 IGF-I의 처리가 분화된 근육 세포인 C2C12 myotube에서 SOCS-3 유전자 발현에 유의한 영향을 미쳤음을 증명하였다. 이러한 결과는 선행연구에서 보고한 운동이 SOCS-3 유전자 발현을 증가시킴에 있어서 IGF-I이 중추적인 역할을 한 것으로 생각된다. 그러나 IGF-I에 의한 SOCS-3 유전자 발현 조절 기전에 있어 관련 신호 전달체계 및 골격근 관련 유전자 발현에 미치는 영향에 관한 연구는 보다 더 이루어져야 할 것이라 사료된다.

다국어 초록 (Multilingual Abstract)

It is well known that both insulin-like growth factor-I and suppressor of cytokine signaling-3 (SOCS-3) are known to modulate various aspects of physiology in skeletal muscle cells. Furthermore, although SOCS-3 expression is related to insulin resistance in non-skeletal muscle cells and is known to interact with insulin-like growth factor-I receptor, the effect of IGF-I on SOCS-3 gene expression in skeletal muscle cells is presently unknown. C2C12 myotubes were treated with different concentrations (0-200 ng/ml) of IGF-I or for various periods of time (3-72 hr). Immunofluorescent staining image revealed that IGF-I induced SOCS-3 protein expression in a dose-dependent manner. Western blot data also showed that SOCS-3 proteins were induced by IGF-I (200 ng/ml) in C2C12 myotubes in a time-dependent manner. The level of SOCS-3 mRNA was also significantly increased after 3hr of IGF-I (10-100 ng/ml) treatment. However, the levels of SOCS-3 mRNA were significantly decreased after 24 and 48 hr of IGF-I (10-100 ng/ml) treatment compared to the control. In conclusion, SOCS-3 protein is induced by IGF-I treatment in C2C12 skeletal muscle cells and this induction is regulated pretranslationally. The modulating effect of IGF-I on SOCS-3 expression may be an important regulator of gene expression in skeletal muscle cells.

목차 (Table of Contents)

• 서론
• 재료 및 방법
• 결과
• 고찰
• References
• 초록

참고문헌 (Reference)

1 Cacalano, N. A., "Tyrosine-phosphorylated SOCS-3 inhibits STAT activation but binds to p120 RasGAP and activates Ras" 3 : 460-465, 2001

2 Alexander, W. S, "The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response" 22 : 503-529, 2004

3 Shi, H., "Suppressor of cytokine signaling 3 is a physiological regulator of adipocyte insulin signaling" 279 : 34733-34740, 2004

4 Rieusset, J., "Suppressor of cytokine signaling 3 expression and insulin resistance in skeletal muscle of obese and type 2 diabetic patients" 53 : 2232-2241, 2004

5 Ueki, K., "Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms" 24 : 5434-5446, 2004

6 Dey, B. R., "Suppressor of cytokine signaling (SOCS)-3 protein interacts with the insulin-like growth factor-I receptor" 278 : 38-43, 2000

7 Glass, D. J, "Skeletal muscle hypertrophy and atrophy signaling pathways" 37 : 1974-1984, 2005

8 Bodell, P. W., "Skeletal muscle growth in young rats is inhibited by chronic exposure to IL-6 but preserved by concurrent voluntary endurance exercise" 106 : 443-453, 2009

9 Trenerry, M. K., "STAT3 signaling is activated in human skeletal muscle following acute resistance exercise" 102 : 1483-1489, 2007

10 Takeda, K, "STAT family of transcription factors in cytokine-mediated biological responses" 11 : 199-207, 2000

11 Diao, Y., "SOCS1, SOCS3, and PIAS1 promote myogenic differentiation by inhibiting the leukemia inhibitory factor-induced JAK1/STAT1/STAT3 pathway" 29 : 5084-5093, 2009

12 Emanuelli, B., "SOCS-3 is an insulin-induced negative regulator of insulin signaling" 275 : 15985-15991, 2000

13 Emanuelli, B, "SOCS-3 inhibits insulin signaling and is up-regulated in response to tumor necrosis factor-alpha in the adipose tissue of obese mice" 276 : 47944-47949, 2001

14 Spangenburg, E. E, "SOCS-3 induces myoblast differentiation" 280 : 10749-10758, 2005

15 Rui, L., "SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2" 277 : 42394-42399, 2002

16 Auernhammer, C. J., "SOCS proteins: modulators of neuroimmunoendocrine functions. Impact on corticotroph LIF signaling" 917 : 658-664, 2000

17 Lebrun, P, "SOCS proteins causing trouble in insulin action" 192 : 29-36, 2008

18 Jennische, E, "Regenerating skeletal muscle cells express insulin-like growth factor I" 130 : 327-332, 1987

19 Hansen, J. A., "Mechanism of inhibition of growth hormone receptor signaling by suppressor of cytokine signaling proteins" 13 : 1832-1843, 1999

20 Yadav, A., "JAK/STAT3 pathway is involved in survival of neurons in response to insulin-like growth factor and negatively regulated by suppressor of cytokine signaling-3" 280 : 31830-31840, 2005

21 Wallenius, V., "Interleukin-6-deficient mice develop mature-onset obesity" 8 : 75-79, 2002

22 Weigert, C., "Interleukin-6 acts as insulin sensitizer on glycogen synthesis in human skeletal muscle cells by phosphorylation of Ser473 of Akt" 289 : E251-257, 2005

23 Benedetti, F., "Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation" 99 : 643-650, 1997

24 Park, P, "Insulin-like growth factor I (IGF-I) measurements in growth hormone (GH) therapy of idiopathic short stature (ISS)" 15 : S13-S20, 2005

25 Sadowski, C. L., "Insulin Induction of SOCS-2 and SOCS-3 mRNA expression in C2C12 Skeletal Muscle Cells Is Mediated by Stat5" 276 : 20703-20710, 2001

26 Haddad, F., "IL-6-induced skeletal muscle atrophy" 98 : 911-917, 2005

27 Galvin, C. D., "IGF-I receptor mediates differentiation of primary cultures of mouse skeletal myoblasts" 200 : 19-29, 2003

28 Yaspelkis, B. B. III., "High-fat feeding increases insulin receptor and IRS-1 coimmunoprecipitation with SOCS-3, IKKalpha/beta phosphorylation and decreases PI-3 kinase activity in muscle" 296 : R1709-R1715, 2009

29 Nielsen, C., "Growth hormone signaling in vivo in human muscle and adipose tissue: impact of insulin, substrate background, and growth hormone receptor blockade" 93 : 2842-2850, 2008

30 Tollet-Egnell, P., "Growth hormone regulation of SOCS-2, SOCS-3, and CIS messenger ribonucleic acid expression in the rat" 140 : 3693-3704, 1999

31 Florini, J. R., "Growth hormone and the insulin-like growth factor system in myogenesis" 16 : 481-517, 1996

32 Holloszy, J. O, "Exercise-induced increase in muscle insulin sensitivity" 99 : 338-343, 2005

33 Hawley, J. A, "Exercise training-induced improvements in insulin action" 192 : 127-135, 2008

34 Spangenburg, E. E, "Exercise increases SOCS-3 expression in rat skeletal muscle: potential relationship to IL-6 expression" 572 : 839-848, 2006

35 Kim, C. H., "Effects of high-fat diet and exercise training on intracellular glucose metabolism in rats" 278 : E977-E984, 2000

36 Kakisis, J. D., "Effects of cyclic strain on vascular cells" 11 : 17-28, 2004

37 Jandziszak, K., "Disturbances of growth hormone-insulin-like growth factor axis and response to growth hormone in acidosis" 275 : R120-R128, 1998

38 Ueki, K., "Central role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouse" 10422-10427, 2004

39 McLellan, A. S., "An E box in the exon 1 promoter regulates insulin-like growth factor-I expression in differentiating muscle cells" 291 : C300-C307, 2006

40 Steppan, C. M., "Activation of SOCS-3 by resistin" 25 : 1569-1575, 2005

41 Kraegen, E. W., "A potent in vivo effect of ciglitazone on muscle insulin resistance induced by high fat feeding of rats" 38 : 1089-1093, 1989